<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Info | wechat-feeds</title><link>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</link><description>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 10 Jun 2021 17:18:50 +0800</pubDate><image><url>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Info | wechat-feeds</title><link>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>恒瑞PD-1新适应症获批：一线治疗鼻咽癌</title><link>https://mp.weixin.qq.com/s/mQrf3sq_z1-bbxGpHtt2Pw</link><description></description><content:encoded><![CDATA[恒瑞PD-1新适应症获批：一线治疗鼻咽癌]]></content:encoded><pubDate>Thu, 10 Jun 2021 15:52:09 +0800</pubDate></item><item><title>首仿！恒瑞「阿齐沙坦片」获批上市</title><link>https://mp.weixin.qq.com/s/yEyiTXghF1Pkl5LNNSwSRA</link><description></description><content:encoded><![CDATA[首仿！恒瑞「阿齐沙坦片」获批上市]]></content:encoded><pubDate>Thu, 10 Jun 2021 15:52:09 +0800</pubDate></item><item><title>辉瑞20价肺炎球菌结合疫苗获FDA批准上市</title><link>https://mp.weixin.qq.com/s/cDpkQSSgki1kKbX1irI7KA</link><description></description><content:encoded><![CDATA[辉瑞20价肺炎球菌结合疫苗获FDA批准上市]]></content:encoded><pubDate>Thu, 10 Jun 2021 15:52:09 +0800</pubDate></item><item><title>免费通道！在BioChina，遇见创新者！</title><link>https://mp.weixin.qq.com/s/QYG1TT1TTPPNPc9br4ZHcQ</link><description></description><content:encoded><![CDATA[免费通道！在BioChina，遇见创新者！]]></content:encoded><pubDate>Thu, 10 Jun 2021 15:52:09 +0800</pubDate></item><item><title>活动报名 | 第五届南京创新药物研发高峰论坛暨细胞&amp;基因治疗项目路演专场</title><link>https://mp.weixin.qq.com/s/wzP5meoP4or9KuRf5CyTlg</link><description></description><content:encoded><![CDATA[活动报名 | 第五届南京创新药物研发高峰论坛暨细胞&基因治疗项目路演专场]]></content:encoded><pubDate>Thu, 10 Jun 2021 15:52:09 +0800</pubDate></item><item><title>新药仿药CMC研发交流论坛 期待您的参与</title><link>https://mp.weixin.qq.com/s/zYKsmbtgk1HzLubtbSPMFg</link><description></description><content:encoded><![CDATA[新药仿药CMC研发交流论坛 期待您的参与]]></content:encoded><pubDate>Thu, 10 Jun 2021 15:52:09 +0800</pubDate></item><item><title>泽璟制药多纳非尼获批上市！首个国产肝癌一线靶向药</title><link>https://mp.weixin.qq.com/s/ws5vOj2Ht1QePBVEBblIdQ</link><description></description><content:encoded><![CDATA[泽璟制药多纳非尼获批上市！首个国产肝癌一线靶向药]]></content:encoded><pubDate>Wed, 09 Jun 2021 09:53:39 +0800</pubDate></item><item><title>2021年5月 | 全球医药交易概况：多笔超10亿美元的重磅交易，AI赋能医药研发热度不减</title><link>https://mp.weixin.qq.com/s/dLAx42fZA_PTk7xX62Mr5w</link><description></description><content:encoded><![CDATA[2021年5月 | 全球医药交易概况：多笔超10亿美元的重磅交易，AI赋能医药研发热度不减]]></content:encoded><pubDate>Tue, 08 Jun 2021 17:53:13 +0800</pubDate></item><item><title>Biogen阿尔茨海默病新药怎么用？【附说明书下载】</title><link>https://mp.weixin.qq.com/s/94p8TTfPSqc-7Lbqbi9DQA</link><description></description><content:encoded><![CDATA[Biogen阿尔茨海默病新药怎么用？【附说明书下载】]]></content:encoded><pubDate>Tue, 08 Jun 2021 17:53:13 +0800</pubDate></item><item><title>首仿！恒瑞医药「阿齐沙坦片」即将获批上市</title><link>https://mp.weixin.qq.com/s/i81ZqKsvBVWbjL13fWZ5cw</link><description></description><content:encoded><![CDATA[首仿！恒瑞医药「阿齐沙坦片」即将获批上市]]></content:encoded><pubDate>Tue, 08 Jun 2021 17:53:13 +0800</pubDate></item><item><title>和黄医药「索凡替尼胶囊」新适应症即将获批</title><link>https://mp.weixin.qq.com/s/KseLeNzAFYxeQd6pxQbhCg</link><description></description><content:encoded><![CDATA[和黄医药「索凡替尼胶囊」新适应症即将获批]]></content:encoded><pubDate>Tue, 08 Jun 2021 17:53:13 +0800</pubDate></item><item><title>百济神州PD-1第7项适应症上市申请获受理</title><link>https://mp.weixin.qq.com/s/ZgooGBxiO6qnYSaIoXI40g</link><description></description><content:encoded><![CDATA[百济神州PD-1第7项适应症上市申请获受理]]></content:encoded><pubDate>Tue, 08 Jun 2021 17:53:13 +0800</pubDate></item><item><title>恒瑞PD-1新适应症即将获批：一线治疗鼻咽癌</title><link>https://mp.weixin.qq.com/s/d5tfqlAV9xx7hgEcEhYY2A</link><description></description><content:encoded><![CDATA[恒瑞PD-1新适应症即将获批：一线治疗鼻咽癌]]></content:encoded><pubDate>Mon, 07 Jun 2021 22:10:20 +0800</pubDate></item><item><title>阿斯利康「奥拉帕利片」新适应症即将获批，治疗前列腺癌</title><link>https://mp.weixin.qq.com/s/v8bKFa8vYWf7QkgrPPg8AA</link><description></description><content:encoded><![CDATA[阿斯利康「奥拉帕利片」新适应症即将获批，治疗前列腺癌]]></content:encoded><pubDate>Mon, 07 Jun 2021 22:10:20 +0800</pubDate></item><item><title>百济神州「泽布替尼胶囊」新适应症即将获批</title><link>https://mp.weixin.qq.com/s/tmVyO16yjFn4LQqBHvfNzw</link><description></description><content:encoded><![CDATA[百济神州「泽布替尼胶囊」新适应症即将获批]]></content:encoded><pubDate>Mon, 07 Jun 2021 22:10:20 +0800</pubDate></item><item><title>直播预告 | ASCO 2021最值得关注Top10新机会深度解析</title><link>https://mp.weixin.qq.com/s/RE9-gqSEUJmjawMcau565Q</link><description></description><content:encoded><![CDATA[直播预告 | ASCO 2021最值得关注Top10新机会深度解析]]></content:encoded><pubDate>Mon, 07 Jun 2021 22:10:20 +0800</pubDate></item><item><title>ASCO | 百济神州公布替雷利珠单抗、帕米帕利关键临床研究结果</title><link>https://mp.weixin.qq.com/s/igGi6le4p-rjLAxe-yawPg</link><description></description><content:encoded><![CDATA[ASCO | 百济神州公布替雷利珠单抗、帕米帕利关键临床研究结果]]></content:encoded><pubDate>Mon, 07 Jun 2021 22:10:20 +0800</pubDate></item><item><title>恒瑞吡咯替尼+曲妥珠单抗+化疗术前治疗乳腺癌III期研究成功</title><link>https://mp.weixin.qq.com/s/88Zjrn_puvGn2AT-JQZRLQ</link><description></description><content:encoded><![CDATA[恒瑞吡咯替尼+曲妥珠单抗+化疗术前治疗乳腺癌III期研究成功]]></content:encoded><pubDate>Mon, 07 Jun 2021 22:10:20 +0800</pubDate></item><item><title>首个国产重组凝血因子VIII临床研究正式刊登于国际权威杂志《Haemophilia》</title><link>https://mp.weixin.qq.com/s/vV4BN8cYHEOUcvZnYPFXQw</link><description></description><content:encoded><![CDATA[首个国产重组凝血因子VIII临床研究正式刊登于国际权威杂志《Haemophilia》]]></content:encoded><pubDate>Sun, 06 Jun 2021 23:50:02 +0800</pubDate></item><item><title>ASCO 2021：新机会TOP10</title><link>https://mp.weixin.qq.com/s/ne1G1Ciw7pXljgO8hKJRuQ</link><description></description><content:encoded><![CDATA[ASCO 2021：新机会TOP10]]></content:encoded><pubDate>Sun, 06 Jun 2021 23:50:02 +0800</pubDate></item></channel></rss>